Apex Science & Engineering Corp.

TWSE:3052 Stok Raporu

Piyasa değeri: NT$2.4b

Apex Science & Engineering Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Apex Science & Engineering.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Construction kazanç büyümesi15.7%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Apex Science & Engineering (TWSE:3052) Will Pay A Dividend Of NT$0.40

Aug 10
Apex Science & Engineering (TWSE:3052) Will Pay A Dividend Of NT$0.40

The Return Trends At Apex Science & Engineering (TWSE:3052) Look Promising

Aug 07
The Return Trends At Apex Science & Engineering (TWSE:3052) Look Promising

Apex Science & Engineering's (TWSE:3052) Conservative Accounting Might Explain Soft Earnings

Mar 22
Apex Science & Engineering's (TWSE:3052) Conservative Accounting Might Explain Soft Earnings

Investors Aren't Buying Apex Science & Engineering Corp.'s (TPE:3052) Earnings

Apr 07
Investors Aren't Buying Apex Science & Engineering Corp.'s (TPE:3052) Earnings

Apex Science & Engineering Corp.'s (TPE:3052) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Mar 19
Apex Science & Engineering Corp.'s (TPE:3052) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

What Can The Trends At Apex Science & Engineering (TPE:3052) Tell Us About Their Returns?

Feb 26
What Can The Trends At Apex Science & Engineering (TPE:3052) Tell Us About Their Returns?

Is It Worth Buying Apex Science & Engineering Corp. (TPE:3052) For Its 4.1% Dividend Yield?

Feb 05
Is It Worth Buying Apex Science & Engineering Corp. (TPE:3052) For Its 4.1% Dividend Yield?

Apex Science & Engineering (TPE:3052) Seems To Use Debt Quite Sensibly

Jan 19
Apex Science & Engineering (TPE:3052) Seems To Use Debt Quite Sensibly

Did You Miss Apex Science & Engineering's (TPE:3052) 53% Share Price Gain?

Jan 01
Did You Miss Apex Science & Engineering's (TPE:3052) 53% Share Price Gain?

Is Apex Science & Engineering Corp.'s (TPE:3052) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Dec 14
Is Apex Science & Engineering Corp.'s (TPE:3052) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Should You Use Apex Science & Engineering's (TPE:3052) Statutory Earnings To Analyse It?

Nov 26
Should You Use Apex Science & Engineering's (TPE:3052) Statutory Earnings To Analyse It?

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Apex Science & Engineering yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

TWSE:3052 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (TWD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
6/30/20243,2731962,1072,109N/A
3/31/20243,4702091,5021,506N/A
12/31/20233,4842051,2331,236N/A
9/30/20233,374213-1,524-1,521N/A
6/30/20233,232224-1,046-1,038N/A
3/31/20232,950210141148N/A
12/31/20222,952207397403N/A
9/30/20222,780174604610N/A
6/30/20222,896123827828N/A
3/31/20223,507111444445N/A
12/31/20213,615103543545N/A
9/30/20213,975986062N/A
6/30/20214,875233440443N/A
3/31/20215,4633701,0341,035N/A
12/31/20205,218316783785N/A
9/30/20208,7765213,5443,546N/A
6/30/20207,4933693,4483,450N/A
3/31/20205,8601782,1942,197N/A
12/31/20195,6241752,4342,437N/A
9/30/20191,105-91-859-856N/A
6/30/20191,035-109-1,959-1,957N/A
3/31/20191,018-144-2,622-2,622N/A
12/31/20181,071-136-2,806-2,804N/A
9/30/20182,02089-2,157-2,155N/A
6/30/20182,803125-2,403-2,400N/A
3/31/20183,126186N/A-470N/A
12/31/20173,901201N/A589N/A
9/30/20174,02745N/A860N/A
6/30/20173,80142N/A2,149N/A
3/31/20173,61945N/A623N/A
12/31/20162,88844N/A-503N/A
9/30/20162,35761N/A-742N/A
6/30/20162,30892N/A-1,254N/A
3/31/20162,440137N/A-1,411N/A
12/31/20152,514143N/A-1,463N/A
9/30/20153,099192N/A-2,124N/A
6/30/20152,855121N/A-1,956N/A
3/31/20153,14641N/A-1,901N/A
12/31/20143,692186N/A-207N/A
9/30/20147,2241,143N/A2,150N/A
6/30/20148,6241,369N/A3,264N/A
3/31/20148,6221,406N/A3,679N/A
12/31/20138,1761,253N/A1,982N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if 3052's forecast earnings growth is above the savings rate (1%).

Kazançlar ve Piyasa: Insufficient data to determine if 3052's earnings are forecast to grow faster than the TW market

Yüksek Büyüme Kazançları: Insufficient data to determine if 3052's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if 3052's revenue is forecast to grow faster than the TW market.

Yüksek Büyüme Geliri: Insufficient data to determine if 3052's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if 3052's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin